iBio, Inc. ( IBIO) - Key Metrics
IBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0 | -$0.10 | -$0.06 | -$0.06 |
| 2026Q3 | $0 | -$0.06 | -$0.05 | -$0.05 |
| 2026Q2 | $0 | -$0.09 | -$0.05 | -$0.06 |
| 2026Q1 | $0 | -$0.11 | -$0.11 | -$0.11 |
| 2025Q4 | $0.01 | -$0.31 | -$0.28 | -$0.28 |
IBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -7.29 |
| 2026Q3 | 0% | -7.35 |
| 2026Q2 | 0% | -5.32 |
| 2026Q1 | 0% | -1.88 |
| 2025Q4 | 0% | -0.62 |
IBIO
Price: $1.19
52 week price:
Earnings Per Share: -0.32 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Market Capitalization: 64.6 million